Author:
Liu T.-L.,Shimada H.,Ochiai T.,Shiratori T.,Lin S.-E.,Kitagawa M.,Harigaya K.,Maki M.,Oka M.,Abe T.,Takiguchi M.,Hiwasa T.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Biochemistry (medical),Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology
Reference60 articles.
1. Isono K, Ochiai T. Recent advances of treatment of cancer of the esophagus (review). Ann Cancer Res Ther 1992; 1: 9–16.
2. Houghton JA, Weiss KD, Williams LG, Torrance PM, Houghton PJ. Relationship between 5-fluoro-2’-deoxyuridylate, 2′-deoxyuridylate, and thymidylate synthase activity subsequent to 5-fluorouracil administration, in xenografts of human colon adenocarcinomas. Biochem Pharmacol 1986; 35: 1351–1358.
3. Aschele C, Sobrero A, Faderan MA, Bertino JR. Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedules. Cancer Res 1992; 52: 1855–1864.
4. Oka S. A review of clinical studies of bestatin. Recent Results Cancer Res 1980; 75: 126–132.
5. Bunz F, Dutriaux A, Lengauer C, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497–1501.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献